Navigation Links
NimbleGen names CFO with capital-raising past

Madison, Wis. - NimbleGen Systems, Inc., a supplier of DNA microarrays for genome research, has appointed a new chief financial officer with experience managing large entrepreneurial growth companies.

David Snyder brings more than 15 years of experience in capital raising, finance, and general management in a range of industries, including te......

Full article >>> ded on the Nasdaq.

In addition, Snyder worked for Eagle Industries, Inc., a diversified manufacturing company sponsored by Chicago entrepreneur Sam Zell. Eagle Industries grew to nearly $2 billion in revenue.

Snyder graduated from the Harvard Business School, where he was designated as a Baker Scholar.

Full article >>>
'"/>

Source:wistechnology.com By Chris Fleissner 08/07/06


Related biology technology :

1. NimbleGen researcher to lead $415K DNA project
2. NimbleGen to discontinue IPO after Roches $272.5 million acquisition
3. IPO-bound NimbleGen traveling in fast company
4. Madison biotech NimbleGen files for IPO; one of states best-funded firms
5. Genomics researcher Hood joins NimbleGen board
6. NimbleGen partners with UK biotech firm
7. NimbleGen extends research market reach
8. NimbleGen microarrays speed genetic findings
9. NimbleGen partners with leading researchers
10. NimbleGen closes $8.2m venture round, bringing total to $50m
11. NimbleGen Systems CGS technique helps identify stomach bacteria
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... June 27, 2016 , ... Newly created ... services and solutions to the healthcare market. The company's primary focus is on ... sales and marketing strategies that are necessary to help companies efficiently bring their ...
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... -- The Prostate Cancer Foundation (PCF) is pleased to announce 24 new ... prostate cancer. Members of the Class of 2016 were selected from a pool ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology:
(Date:4/19/2016)... , UAE, April 20, 2016 ... implemented as a compact web-based "all-in-one" system solution for ... biometric fingerprint reader or the door interface with integration ... modern access control systems. The minimal dimensions of the ... readers into the building installations offer considerable freedom of ...
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys ... founding CEO, Barrett Bready , M.D., who returned ... of the original technical leadership team, including Chief Technology ... of Product Development, Steve Nurnberg and Vice President of ... to the company. Dr. Bready served as ...
Breaking Biology News(10 mins):